Arbor Biotechnologies Funding & Investors
Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
arbor.bioTotal Amount Raised: $230,600,000
Arbor Biotechnologies Funding Rounds
Series B
$215,000,000
Series B Investors
Illumina VenturesTao Capital PartnersGreatPoint VenturesLogos Capital ManagementWoodline PartnersOno Venture InvestmentTekla Capital ManagementArch Venture PartnersArrowMark PartnersPiper SandlerVertex PharmaceuticalsSurveyor CapitalRidgeback Capital ManagementAlly Bridge GroupTemasekSection 32Henderson Global InvestorsTCGXT. Rowe PriceDeep Track CapitalSeries A
$15,600,000
Series A Investors
Arch Venture PartnersAlexandria Real Estate Equities
Funding info provided by Diffbot.